{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/premenstrual-syndrome/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"35972086-c065-56c4-b666-e4587fdcf93f","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 2c956dbb-a20e-4938-8be1-c3bd27704089 --><h2>Changes</h2><!-- end field 2c956dbb-a20e-4938-8be1-c3bd27704089 -->","summary":null,"htmlStringContent":"<!-- begin item 8bf1e5d6-3cf2-4dea-bf0e-d2f3e479c44c --><!-- begin field 092d32e1-ff9a-45d3-a972-0ac075bd468f --><p><strong>May 2019</strong> — reviewed. A literature search was conducted in April 2019 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The definition of premenstrual syndrome (PMS) and information on the severity of PMS symptoms have been clarified, and the topic has undergone minor structural changes.</p><ul><li>Advice on the use of complementary treatments and/or dietary supplements — there is limited evidence to support the use of complementary treatments and dietary supplements, including reflexology, acupuncture, calcium and vitamin D, ginkgo biloba, evening primrose oil, vitamin B6, and magnesium, although some women may find them helpful. </li><li>The use of combined oral contraceptives (COCs) — current data suggests use of the COC continuously rather than cyclically.</li></ul><!-- end field 092d32e1-ff9a-45d3-a972-0ac075bd468f --><!-- end item 8bf1e5d6-3cf2-4dea-bf0e-d2f3e479c44c -->","topic":{"id":"668a4b93-2e2a-5933-b12a-a5f9a6837daa","topicId":"f6d48374-0ddd-481d-bd35-f505fee5c47c","topicName":"Premenstrual syndrome","slug":"premenstrual-syndrome","lastRevised":"Last revised in May 2019","chapters":[{"id":"be47d0f4-3261-5657-aed1-da0bf6c8646b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8a1b7572-de88-506c-b0a1-1abc9c2b3400","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"6b9c9d21-76ac-5aeb-8eb1-6691f5ceeebf","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"35972086-c065-56c4-b666-e4587fdcf93f","slug":"changes","fullItemName":"Changes"},{"id":"1514e449-0c67-5287-89db-b28b88262141","slug":"update","fullItemName":"Update"}]},{"id":"77ec7d7d-940c-500d-a1ba-cfbab291e38e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7e8b32dc-1aa1-5788-97c8-df04afc2b0d7","slug":"goals","fullItemName":"Goals"},{"id":"4aaf0515-7ef4-50cd-ac12-5b17be6cd5e2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"0acf2aa6-23e0-570b-b29e-dfdacdf474e8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3c135ec7-461a-543c-b44d-ee843697d5cd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d791fb42-e91f-59e0-8c0c-b0f37f0af9d8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8f27bc31-6f00-5859-81f7-ef752b747fd6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0b4b11ef-5cde-5735-afba-4776dc10d844","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"6f01cc3d-bae7-5d66-94b4-d8e7557c2fef","slug":"definition","fullItemName":"Definition"},{"id":"d13f731a-5216-537d-87a7-ffcd99337439","slug":"causes","fullItemName":"Causes"},{"id":"ab110573-4a7f-55d9-9b69-dd1a01720cc0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"4dcf143b-4961-5298-b7db-b287cf1ca668","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"bc7d0c7b-0738-5636-8178-568fde4f6a9d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"6d13f640-7df8-5329-b316-427a1fb36947","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"62cca645-8d11-506e-b89c-d03bb2e3c67e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"327a606c-ee03-58eb-93aa-e273d6cdaf19","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a4d3cc19-5d97-5502-82ee-faaa3b8d70eb","fullItemName":"Management","slug":"management","subChapters":[{"id":"59536afb-24d2-5bcd-9547-0956da541574","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"420b10d2-e907-5756-8ca3-6664d9a52e79","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9d7a5734-a47f-5d7b-b5c6-402c6770e572","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3ad740b3-87b5-5561-8b71-95159af00e56","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"701680b6-e2f2-5417-8ce9-fbe9fac6dafa","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"17f9f3a8-f341-5f94-b234-1858b76e2615","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"048dd1e9-197a-52dc-b5e6-45257f78f081","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f78990a8-e11f-56f2-a80c-8d73ce908b65","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"81d3d1c5-c389-54b3-8764-34fbee70bb6b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"6b9c9d21-76ac-5aeb-8eb1-6691f5ceeebf","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"3460d72a-59d9-5ee6-9173-1328a1e2af40","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 7d99f7a2-fff2-45d6-aef5-2bf63e3cb543 --><h3>Previous changes</h3><!-- end field 7d99f7a2-fff2-45d6-aef5-2bf63e3cb543 -->","summary":null,"htmlStringContent":"<!-- begin item 41087e45-b4ce-4958-8bc4-9f4761934da0 --><!-- begin field 524bdc24-1f2a-4913-9384-2a7eb3d40944 --><p><strong>January 2014 to March 2014</strong> — reviewed. A literature search was conducted in January 2014 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials (RCTs) published since the last revision of this topic. Diclofenac is no longer recommended for pain because there are safer alternative nonsteroidal anti-inflammatory drugs (NSAIDs).</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>August 2012 </strong>— minor update. Minor typographical errors corrected.</p><p><strong>January 2012 </strong>— minor update. Link to the CKS topic on Depression<em> </em>for more information on prescribing selective serotonin reuptake inhibitors (SSRIs) has been added to the management section. Issued in January 2012.</p><p><strong>June 2011 </strong>— minor update. Link to the CKS topic on Contraception - combined hormonal methods for a full discussion of the risks of COCs added to the management section. Issued in June 2011.</p><p><strong>August to December 2009 </strong>— this is a new CKS topic. The evidence base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 524bdc24-1f2a-4913-9384-2a7eb3d40944 --><!-- end item 41087e45-b4ce-4958-8bc4-9f4761934da0 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}